Clinical trial
An Exploratory Phase 1b Open-label Multi-arm Trial to Evaluate the Safety and Efficacy of CC-90009 in Combination With Anti-Leukemia Agents in Subjects With Acute Myeloid Leukemia
NCT04336982 is registered in ClinicalTrials.gov with Celgene as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Phase 1b Open-label Multi-arm Trial to Evaluate the Safety and Efficacy of CC-90009 in Combination With Anti-Leukemia Agents in Subjects With Acute Myeloid Leukemia
- Lead sponsor
- Celgene
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- August 5, 2020
- Completion date
- April 5, 2024
- Enrollment
- 22 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.